Published in Managed Care Business Week, June 20th, 2006
This trend article about University of Auckland is an immediate alert from IncRx to identify developing directions of research.
"The pVHL suppresses tumor formation by binding the alpha subunits of hypoxia-inducible-factors responsible for stimulating tumor angiogenesis and glycolysis, and targeting them for ubiquitination and proteasomal destruction. Loss of pVHL leads to tumorigenesis and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week